Expert consensus on clinical application of Compound Phellodendron Liquid Coating for mixed hemorrhoids(2025 edition)YANG Hui-ju, LIU Dian-wenChinese Journal of New Drugs2025, No.19202026-08Comprehensive clinical evaluation of hyzetimibe in the treatment of primary hypercholesterolemiaJIANG Li-fan, SHAN Wen-ya, LIU Lin et al.Chinese Journal of New Drugs2025, No.21202026-08Discussion on clinical pharmacology of novel anti-obesity drugs:glucagon-like peptide-1 receptor agonistsWANG Jing, LI Li, WEI Chun-minChinese Journal of New Drugs2025, No.23102026-08Efficacy evaluation of Shugan Jianpi Yangxin Prescription for insomnia disorder:a multicenter,randomized,double-blinded,placebo controlled clinical trialWANG Xu, ZHANG Jie, ZHAO Min et al.Chinese Journal of New Drugs2025, No.21102026-08Considerations on pharmaceutical research of co-crystal drugsMA Jun-wei, LIU Juan, REN Lian-jieChinese Journal of New Drugs2025, No.22102026-08Research progress and pharmaceutical considerations on therapeutic cancer vaccinesWANG Xue, LI Qian, YANG Fei et al.Chinese Journal of New Drugs2025, No.24102026-08Advances in artificial intelligence-driven neoantigen prediction algorithmLI Qian, WANG Xue, JIN Xiang-wan-er et al.Chinese Journal of New Drugs2025, No.24102026-08Comparison of China-Europe examination of patient-group-specific medical use patents under the background of precision medicine:from the perspective of patient population based on physiological indicatorsLI Yan-liChinese Journal of New Drugs2026, No.06102026-08Expert consensus on the clinical application of Compound Huangbai Liquid Liniment for the treatment of perianal abscess and anal fistulaZHANG Li-ze, ZHAO GangChinese Journal of New Drugs2025, No.20102026-08Real-world clinical study on the efficacy and safety of Honghua Ruyi Wan in treating primary dysmenorrheaZHANG Ke-jun, NIU Bing-qian, LI Qian et al.Chinese Journal of New Drugs2025, No.21102026-08Trilaciclib in the prevention of chemotherapy-induced myelosuppression in extensive stage small cell lung cancer:a systematic review and Meta-analysisWANG Zhen-huan, ZHAO Ying, QIU Ting-ting et al.Chinese Journal of New Drugs2025, No.21102026-08Research progress on the mechanism of Codonopsis pilosula in treating coronary heart diseaseKANG Rong-feng, YAO Yu-li, NAN Dan-hui et al.Chinese Journal of New Drugs2025, No.21102026-08Application of organoids in endometrial physiological models,disease mechanisms and therapeutic researchTIAN Shu-ting, LIU Li, DENG Yi-fangChinese Journal of New Drugs2025, No.19102026-08Cost-utility analysis of dupilumab vs omalizumab in the treatment of severe asthmaXU Nuo-ming, JIANG Xin-yue, HE Xiao-ningChinese Journal of New Drugs2025, No.19102026-08Analysis patent applications in therapeutic anti-tumor antibodiesBI Qing, LI JieChinese Journal of New Drugs2025, No.23102026-08Research on the influence of artificial intelligence technology on innovation efficiency of pharmaceutical manufacturing industryZHANG Wen-lin, WANG Shu-lingChinese Journal of New Drugs2026, No.01102026-08Quality management practice of vaccine trial research institutionsFENG Tian, ZHANG Rui-zhi, GUAN Qing-hu et al.Chinese Journal of New Drugs2026, No.02102026-08Analysis of adverse reactions in blood system caused by fulvestrantMA Bing-jie, WANG Yu, CANG Ai-junChinese Journal of New Drugs2025, No.19002026-08Practice and consideration on the management of human genetic resources in drug clinical research under new regulationsNI Qi, LIU YiChinese Journal of New Drugs2025, No.19002026-08Characteristics analysis of phase Ⅱ clinical trials of new Chinese medicine from 2015 to 2024LEI Xiang, ZHAO Chen, DAI Shun et al.Chinese Journal of New Drugs2025, No.23002026-08 